This is best highlighted with the switch from the FGFR3-IIIb isoform to the oncogenic FGFR3-IIIc isoform; this alternative splicing event has been shown to promote invasiveness in prostate and bladder cancers [26,27]. The gene discussed is FGFR3; the disease is urinary bladder carcinoma.